DXCM stock news · DexCom, Inc.

Stories about DexCom, Inc. (DXCM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DXCM

Follow DexCom, Inc. (DXCM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 31, 2026, 10:46 AM ET · Market
Several analysts changed their price predictions for DexCom, Inc. after the company shared its third-quarter results.
Good for DXCM
Four analysts raised their DexCom share-price estimates and kept favorable ratings. JP Morgan kept a Neutral rating but also raised its estimate, making the news positive overall.
Oct 29, 2026, 7:29 PM ET · Deal
DexCom's board has approved a plan to buy back $1 billion of its own shares.
Good for DXCM
DexCom approved a plan to buy back up to $1 billion of its shares by 2027. The plan could return money to shareholders, making the news positive for DexCom.
Oct 29, 2026, 7:29 PM ET · Results
DexCom shared its Q3 2026 earnings, showing $1.34 billion in sales and expects higher revenue for the year.
Good for DXCM
DexCom beat analyst estimates for sales and adjusted profit per share, then raised its 2026 sales forecast. Continued growth in glucose monitoring points to a stronger business outlook.
Oct 29, 2026, 5:52 PM ET · Results
DexCom shares what happened during their earnings call for the third quarter of 2026.
Good for DXCM
DexCom grew sales and gained U.S. share in Q3. New products and added factory capacity support its business, though broader coverage still awaits a CMS decision.